Chinook Therapeutics, Inc. (KDNY) Social Stream



Chinook Therapeutics, Inc. (KDNY): $10.92

-0.14 (-1.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KDNY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 504

in industry

Chinook Therapeutics Inc (KDNY) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Chinook Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
7 $40 $25 $32.71 $11.57 182.71%

The Trend in the Analyst Price Target


Over the past 92 days, KDNY's average price target has gone up $1.14.

KDNY reports an average of 110.97% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-08 7 40 25 32.71 13.54 141.58%
2021-09-04 7 40 25 32.71 12.99 151.81%
2021-07-12 7 40 25 31.57 14.86 112.45%
2021-07-10 7 40 25 31.57 14.79 113.46%
2021-06-08 7 40 25 31.57 18.50 70.65%
2021-06-05 7 40 25 31.57 16.81 87.8%
2021-04-21 7 40 25 31.71 14.89 112.96%
2021-01-18 6 38 25 30.33 15.20 99.54%
2021-01-16 6 38 25 30.33 15.20 99.54%
2020-11-22 4 38 25 30.75 13.98 119.96%

KDNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 4 4 0 0 0 8

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The upside potential (average analyst target price relative to current price) of KDNY is greater than 88.43% of all US stocks.
  • Chinook Therapeutics Inc's variance in analysts' estimates is lower than 27.89% of all US stocks.
  • The number of analysts covering the stock of KDNY is higher than 70.17% of Pharmaceutical Products stocks.
  • The average analyst price target of KDNY is greater than 65.41% of Pharmaceutical Products stocks.

Stocks similar to Chinook Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, PASG and CGEN.

Is KDNY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7146 seconds.